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1 Current address: IRBA/CRSSA, UMR-MD1, La TroncComplementation for virulence of a non-polar virB5 mutant in Brucella suis 1330 was not possible
using a pBBR-based plasmid but was with low copy vector pGL10. Presence of the pBBR-based rep-
licon in wildtype B. suis had a dominant negative effect, leading to complete attenuation in J774
macrophages. This was due to pleiotropic effects on VirB protein expression due to multiple copies
of the virB promoter region and over expression of VirB5. Functional complementation of mutants
in individual components of multiprotein complexes such as bacterial secretion systems, are often
problematic; this study highlights the importance of using a low copy vector.
 2012 Federation of European Biochemical Societies. Published by Elsevier B.V.1. Introduction
Type IV secretion systems (T4SS) are multiprotein complexes
which can mediate the transfer of nucleoprotein and protein sub-
strates across the bacterial cell envelope to bacterial recipients
for plasmid spread, and to eukaryotic hosts for survival during
establishment of pathogenic or symbiotic relationships [1]. T4SS
are major virulence factors for several pathogens of plants and ani-
mals, including Brucella. Brucella causes brucellosis, a major bacte-
rial zoonosis resulting in abortion in animals and a serious disease
with chronic undulant fever in humans [2]. The virulence of
Brucella requires its VirB T4SS, which is essential for the establish-
ment of its intracellular niche in macrophages and epithelial cells
[3–5]. The VirB system is equally important for virulence in the
mouse model of infection [6] and in natural hosts [7], and thus a
major target of study to unravel its precise role in virulence.
Structure/function studies have centred on the prototype VirB/
D4 T4SS of the plant pathogen Agrobacterium tumefaciens and the
Tra system of plasmid pKM101. The current model predicts a dy-
namic multiprotein machinery [8–10], with a pilus like structure
exposed at the bacterial surface. This pilus is built up of the majoral Societies. Published by Elsevier
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he, France.subunit VirB2, and the minor component VirB5, which is localised
at the pilus tip [11]. VirB5 is essential for Brucella virulence [12,
this work]. We encountered difﬁculties in complementing a non-
polar deletion virB5 mutant using a pBBR-based vector. Here we
show that both multiple copies of the virB operon promoter se-
quence and over expression of VirB5 had pleiotropic effects that
disrupted VirB function.
2. Materials and methods
2.1. Bacterial strains and plasmids
All bacterial strains, plasmids and primers used in this study are
listed in Table 1. Unless stated, Brucella suis was grown in
Trypticase Soy (TS) broth, and Escherichia coli in Luria-Bertani
(LB) broth. Expression from the lac promoter in pBBRplac–virB5 was
induced with 1 mM IPTG.
2.2. Plasmid constructions
The virB5 gene was ampliﬁed using B. suis 1330 chromosomal
DNA as a template with primers virB5-1 and virB5-2 (Table 1).
For expression under control of the virB promoter, the PCR frag-
ment was digested with NdeI/BamHI and ligated into similarly di-
gested pIN34 [13], named pBBRpvirB in the text for clarity, to
yield pIN144 (pBBRpvirB–virB5). Plasmid pIN146 (pGLpvirB–virB5) was
constructed by ligation of an XbaI/PstI fragment of pIN144 into
pGL10. For expression from the lac promoter, the NdeI/KpnIB.V. Open access under CC BY-NC-ND license.
Table 1
Strains, plasmids and primers used in this study.
Synonym used
in text
Relevant characteristics Source or
reference
B. suis strains
1330 WT 1330 Wild type ATCC 23444T
bIN1929 1330 (pIN34) This study
bIN1909 1330 (pIN144) This study
bIN1900 virB5 1330 virB5 non-polar mutant This study
bIN1901 1330 virB5, (pIN 144) This study
bIN1908 1330 virB5, (pIN 146) This study
E. coli strain
DH5a Fu lacZDM15 D(lacZYA-argF)U169 endA1 recA1 hsdR17 (rKm
þ
K ) supE44 thi-1 DgyrA96 relA1
Plasmids
pIN11 Suicide vector, Sucrs Cmr This study
pIN143 pIN11-derivative carrying 400 bp ﬂanks of virB5, resulting in precise virB5 deletion, Sucrs Cmr This study
pBBR1-
MCS
Broad host range plasmid, medium copy number (10–12 copies per genome equivalent [32] Cmr [33]
pIN34 pBBRpvirB pBBR1-MCS derived plasmid carrying 1.1 kb fragment of the B. suis virB promoter, Cmr [13]
pIN144 pBBRpvirB–virB5 pIN34-derived plasmid containing virB5 translationally fused to pvirB, Cmr This study
pGL10 Broad host range RK2-based low copy number cloning vector, low copy number (2–4 copies per genome equivalent),
Kmr
[30]
pIN146 pGLpvirB–virB5 pGL10 derivative carrying a pvirB–virB5 expression unit, Kmr This study
pSRKKm pBBR1-derived plasmid containing a reengineered lacIQ–promoter–lac operator complex in which cloned genes are
strongly repressed in the absence of inducer
[14]
pIN164 pBBRplac–virB5 pBBR derived plasmid containing plac–virB5 expression unit, Kmr This study
Primers
virB5-1 GAGGAATTCCATATGAAGAAGATAATTCTCAGCTTC, NdeI site underlined
virB5-2 GACGGGATCCTTAATAGGCGGCTTCCAGTGC, BamHI site underlined
B5MutUF CGGGATCCCTACTGGATGGACGAGGCG, BamHI site underlined
B2MutUR GGAATTCCATATGAGTGTCACCTTCCTGTTGATT, NdeI site underlined
B5MutDF GGAATTCCATATGCTACCCGACTAAGGAGTAGA, NdeI site underlined
B5MutDR GCTCTAGATGCGATGTTCCACCCCTTG, XbaI site underlined
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(pBBRplac–virB5).
A suicide vector was constructed by ligation of a 2.7 kb BamHI/
SphI fragment of pSDM3005 [15] containing the sacR gene for neg-
ative selection, in pHSG398 (CmR) (TaKaRa Bio Inc), and named
pIN11.
2.3. Construction of a virB5 non-polar mutant
A mutant of B. suis 1330 with a non-polar deletion of the virB5
gene (bIN1900, virB5 in the text) was constructed as described
previously for virB8 [13]. Both 500 base pair (bp) ﬂanking regions
of virB5 were ampliﬁed by PCR so that ligation of the fragments
would result in a precise deletion of virB5 using primer sets B5Mu-
tUF/B2MutUR and B5MutDF/B5MutDR. The PCR fragments were
digested with BamHI/NdeI or NdeI/XbaI, respectively, and ligated
simultaneously in BamHI/XbaI digested suicide vector pIN11, result-
ing in pIN143. After introduction of pIN143 into 1330 by electropor-
ation, chloramphenicol resistant colonies resulting from single
crossover events were isolated and conﬁrmed by PCR analysis.
Positive colonies were grown overnight in LBmedium (lacking NaCl
and antibiotics) and plated on medium containing 6% (w/v) sucrose
to select for a second excisional recombination event, resulting in
precise deletion of virB5. Chloramphenicol sensitive/sucrose resis-
tant colonies were subjected to PCR and Southern blotting, followed
by sequence analysis to verify the precise deletion of virB5. The non-
polar virB5 mutant was named bIN1900.
2.4. Cell infections
Murine J774 A.1 macrophage-like cells (ATCC) were cultivated
and infected with Brucella with a multiplicity of infection (MOI)
of 50 in a standard gentamicin protection assay as described previ-
ously [3]. The number of colony forming units (CFU) per well for
each time point was expressed as the geometric mean (±standarderror of the mean, S.E.M.) of three wells. All experiments were per-
formed at least 3 times. A Student’s t-test (with two-tailed distri-
bution and equal variance) was performed to determine whether
two strains differed signiﬁcantly (P < 0.05).
2.5. Analysis of VirB expression
To analyse VirB expression, B. suis strains were grown in mini-
mal medium at pH 4.5 as described [16]. Western blot analysis
was performed to detect VirB1, VirB5, VirB9 and VirB10; Bcsp31
was used as a control for equal loading.
3. Results and discussion
3.1. Successful complementation of a virB5 mutant to wild type
virulence levels depends on plasmid copy number
We constructed a non-polar deletion of virB5 (bIN1900), which
was strongly attenuated for virulence in macrophages at 24 h post-
infection (hpi) and 48 hpi (Fig. 1). However, we were unable to re-
store virulence when we complemented the virB5 deletion mutant
with the virB5 gene under the control of the virB promoter using
the medium copy number plasmid pBBR1-MCS (pBBRpvirB–virB5)
(Fig. 1), despite restoration of VirB5 production (Fig. 2c). In con-
trast, virulence was restored when the gene was carried on the
low copy number plasmid pGL10 (pGLpvirB–virB5; Fig. 1). Since ge-
netic complementation studies with individual components of
multiprotein complexes are a recurrent problem, we analysed this
in more detail for VirB5.
3.2. Multiple copies of the virB promoter sequence and overproduction
of VirB5 attenuate virulence of wild type B. suis
The expression of the Brucella virB operon is controlled through
several layers of regulation [17–22]. We have previously suggested
Fig. 1. pGLpvirB–virB5 but not pBBRpvirB–virB5 complements a B. suis 1330 virB5mutant.
Replication kinetics of B. suis 1330, virB5 mutant and complemented mutant (with
pBBRpvirB–virB5 or pGLpvirB–virB5) in J774A.1 macrophages. A representative experi-
ment is shown. Wild type 1330 differed signiﬁcantly from the virB5 mutant, and
virB5 (pBBRpvirB–virB5) (P = 0.003, 0.084 at 24 hpi and P = 5  104, 2.5  105 at
48 hpi, respectively). pGLpvirB–virB5 complemented the virB5 mutant signiﬁcantly
(P = 0.003, 0.001 at 24 hpi and 48 hpi, respectively), although not to full virulence
levels of the wild type (48 hpi (P = 0.021)). virB5 (pBBRpvirB–virB5) was as attenuated
as virB5 (P = 0.53, 0.267 at 24 hpi and 48 hpi, respectively).
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might sequester regulatory factors essential for expression of the
chromosomal virB operon or possibly of other genes that are co-
regulated with the virB operon and essential for virulence [3]. A
second possibility is that non-stoichiometric (high) levels of VirB5
could interfere with correct T4SS biogenesis and/or function [12],
as shown for VirB6 of A. tumefaciens [23].Fig. 2. Overproduction of VirB5 and presence of multiple copies of the virB promoter regi
(pBBRpvirB) or (pBBRpvirB–virB5) in J774A.1 macrophages. A representative experiment is
attenuated (P = 0.001, 2.7  105 at 24 hpi and P = 2.5  105, 5.2  104 at 48 hpi, respec
and P = 0.001 at 48 hpi). (B) Immuno blot analysis of wild type 1330, 1330 (pBBRpvirB–
Expression was detected with polyclonal antisera raised against VirB5, VirB9, VirB10 an
mutant, virB5 (pGLpvirB–virB5), and virB5 (pBBRpvirB–virB5). Expression was detected with
kinetics in J774 macrophages of wild type 1330, the virB5mutant, virB5 (pBBRpvirB–virB5) an
with IPTG. At 48 hpi, wild type 1330 and virB5 (pBBRplac–virB5) induced at 0 hpi, 2 hp
(pBBRplac–virB5) non-induced or induced at 24 hpi (P = 0.027 between virB5 (pBBRplac–virB5We introduced pBBRpvirB–virB5 into wild type 1330, ﬁnding that it
had a dominant negative effect, completely abolishing the viru-
lence of the wild type strain (Fig. 2a). To determine the individual
contribution of the presence of multiple virB promoter sequences
that might result in the sequestration of transcription factors, we
analysed the virulence of wild type 1330 carrying pBBRpvirB, an
identical pBBR-based plasmid with the virB promotor, but lacking
the virB5 coding region. This strain was also attenuated in J774
macrophages, although signiﬁcantly less attenuated than wild type
1330 with plasmid pBBRpvirB–virB5 (Fig. 2a). This clearly indicated
that multiple promoter sequences partially contributed to the ob-
served attenuation of 1330 (pBBRpvirB–virB5), but that an additional
effect of over expression of VirB5 contributed to the complete
attenuation seen with pBBRpvirB–virB5 and possibly the inability of
pBBRpvirB–virB5 to fully complement the virB5 mutant. To further
investigate the sequestration of transcription factors, we con-
structed plasmids carrying the putative binding sites for VjbR
and HutC but saw no effects on virulence (data not shown), not
unexpectedly due to the complex regulation of the virB operon.
3.3. Controlled expression of virB5 from a lac promoter partially
complements the virB5 mutant
To further dissect the reason for the observed attenuation of
wild type 1330 by the presence of pBBRpvirB–virB5, we placed the
virB5 gene under the control of a tightly regulated lac promoter
in pSRKKm [14], which would not sequester virB speciﬁc transcrip-
tion factors. Macrophages were infected with virB5 (pBBRplac–virB5)
and virB5 expression was induced at different times with IPTGon attenuate wild type B. suis. (A) Replication kinetics of wild type 1330, virB5, 1330
shown. The virB5 mutant and wild type 1330 (pBBRpvirB–virB5) were signiﬁcantly
tively). 1330 is signiﬁcantly more virulent than 1330 (pBBRpvirB) (P = 0.011 at 24 hpi
virB5) and 1330 (pBBRpvirB). All strains were grown under acid growth conditions.
d Bcsp31 (loading control). (C) Immuno blot analysis of wild type 1330, the virB5
polyclonal antisera raised against VirB5, VirB9, VirB10 and Bcsp31. D. Replication
d virB5 (pBBRplac–virB5), the latter induced at different time points (0, 2, 5, and 24 hpi)
i and 5 hpi are signiﬁcantly different from virB5, virB5 (pBBRplac–virB5) and virB5
) induced at 0 hpi and virB5 (pBBRplac–virB5) induced at 24 hpi).
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to be induced within the ﬁrst 5 h after infection, which is ﬁtting
with previous studies showing intracellular induction of the virB
operon at 3–4 h after uptake, and the importance of early phago-
some acidiﬁcation to induce the virB operon [16,24]. Within those
5 h, better complementation correlated with later time points of
induction of VirB5 expression, suggesting that either increasing
levels of VirB5 reduce virulence or that virB5 expression from the
lac promoter must be coordinated with induction of the rest of
the chromosomal virB operon from its own promoter.
3.4. Pleiotropic effects on VirB protein expression during
complementation
As several regulators have either positive or negative effects on
virB expression by binding to speciﬁc sequences in the promoter re-
gion [17,25], we would expect that an effect on endogenous virB
transcription by the presence of multiple virB sequences would re-
sult in a general reduction of virB expression in the wild type carry-
ing pBBRpvirB. Immunoblot analysis showed that in wild type 1330
(pBBRpvirB), levels of VirB5, VirB9 and VirB10 were indeed slightly
reduced (Fig. 2b). However, additional over expression of VirB5 in
1330 (pBBRpvirB–virB5) led to a greater reduction of VirB9, and even
undetectable VirB10 (Fig. 2b). This reduction in VirB protein levels
correlates with the complete attenuation of 1330 (pBBRpvirB–virB5)
and the inability of pBBRpvirB–virB5 to complement the virB5mutant.
In contrast, in virB5 (pGLpvirB–virB5), with virulence restored to almost
wild type levels, VirB5 and VirB10 levels were intermediate to those
in 1330 and virB5 (pBBRpvirB–virB5) (Fig. 2c). Importantly, VirB10 was
still detectable and VirB5 levels were still higher than those in wild
type 1330, suggesting that some variation in VirB protein levels is
tolerated to reach almost WT levels of complementation.
Other studies have shown that the assembly of a T4SS in the
bacterial envelope is a complex process in which many different,
often transitory, protein–protein interactions occur. Often T4SS ge-
netic complementation studies are difﬁcult and do not result in full
functional complementation to wild type virulence levels
[12,23,26]. The presence of one protein is often required to stabi-
lize another; VirB5 was shown to interact in Agrobacterium with
VirB9 and VirB10 [27,28] and co-expression of the T4SS compo-
nents VirB7 and VirB8 is essential to restore virulence of individual
null mutants [26]. In Agrobacterium, VirB10 plays an essential role
in both substrate translocation and biogenesis of the VirB pilus
[29]. Disturbance of its regulation or stability may have dramatic
effects on T4SS function. Alternatively, an indirect effect on pro-
duction of VirB9, which was shown in A. tumefaciens to be essential
to stabilize VirB10 under speciﬁc conditions of low osmolarity [28],
may play a role in the attenuation of our VirB5 overproducing
strain. Overproduction of VirB5 might also result in mislocalisation
of the protein at the pilus tip [11].
Our data highlight that the choice of promoter and plasmid
replication origin are critical components to ensure optimal levels
of protein of individual T4SS components and not to deregulate
expression of the endogenous operon. The protein levels required
to maintain stoichiometric levels; however, may be different for
each T4SS component under investigation. An easy assay to deter-
mine whether the original multiprotein complex will be deregu-
lated is to verify virulence of the wild type strain containing the
complementing plasmid. A low copy plasmid, with the gene
expressed from its natural promoter is effective in complementation
of a B. suis virB5mutant. This approachhas also beenusedwith other
proteins for which over expression may have inhibitory effects on
bacterial physiology such as the CcrM protein [30]. An alternative
way to ensure ‘perfect’ complementation is to recombine the com-
plementing gene back into the chromosomal virB operon, a strategy
used to complement a B. abortus virB2 mutant [31]. However, thismethod will be too time consuming for studies requiring comple-
mentation with multiple variant alleles, and unfeasible for certain
bacterial species that are difﬁcult to manipulate.
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